En klinisk undersøgelse af supplerende behandling af partiel epilepsi hos børn i alderen 3- 12 år, viser en nummerisk, men ikke statistisk signifikant forskel i den 50% responderrate til fordel for gabapentingruppen sammenlignet med placebo.
A clinical trial of adjunctive treatment of partial seizures in paediatric subjects, ranging in age from 3 to 12 years, showed a numerical but not statistically significant difference in the 50% responder rate in favour of the gabapentin group compared to placebo.